Table 1.
Demographic and baseline patient characteristics
| Characteristics | No of patients (n = 14) | Percent |
|---|---|---|
| Gender | ||
| Male | 6 | 42.9 |
| Female | 8 | 57.1 |
| Age, median (range)/years | 56.5 (14-81) | |
| Performance status (ECOG) | ||
| 0–1 | 13 | 92.9 |
| 2 | 1 | 7.1 |
| Stage at diagnosis (Masaoka-Koga) | ||
| IVa | 3 | 21.4 |
| IVb | 8 | 57.1 |
| Recurrence | 3 | 21.4 |
| Metastatic sites (overlapped) | ||
| Lung | 6 | |
| Liver | 2 | |
| Lymph nodes | 5 | |
| Pleura | 5 | |
| Bone | 3 | |
| Brain | 1 | |
| Histologic subtype | ||
| Squamous cell carcinoma | 12 | 85.7 |
| Lymphoepithelioma-like carcinoma | 1 | 7.1 |
| Undifferentiated carcinoma | 1 | 7.1 |
| Previous chemotherapy | ||
| ADOC | 3 | |
| Cisplatin-irinotecan | 9 | |
| Cisplatin-gemcitabine | 1 | |
| Carboplatin-gemcitabine | 1 | |
No number, ADOC cisplatin, adriamycin, vincristine, and cyclophosphamide